19-3594973-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001060.6(TBXA2R):c.*715C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000185 in 1,531,294 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
TBXA2R
NM_001060.6 3_prime_UTR
NM_001060.6 3_prime_UTR
Scores
7
Clinical Significance
Conservation
PhyloP100: -1.27
Genes affected
TBXA2R (HGNC:11608): (thromboxane A2 receptor) This gene encodes a member of the G protein-coupled receptor family. The protein interacts with thromboxane A2 to induce platelet aggregation and regulate hemostasis. A mutation in this gene results in a bleeding disorder. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_addAF=-0.241824).
BS2
High AC in GnomAd4 at 17 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBXA2R | NM_001060.6 | c.*715C>T | 3_prime_UTR_variant | 3/3 | ENST00000375190.10 | NP_001051.1 | ||
TBXA2R | NM_201636.3 | c.1087C>T | p.Arg363Ter | stop_gained | 4/4 | NP_963998.2 | ||
TBXA2R | XM_011528214.3 | c.*715C>T | 3_prime_UTR_variant | 4/4 | XP_011526516.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBXA2R | ENST00000375190.10 | c.*715C>T | 3_prime_UTR_variant | 3/3 | 1 | NM_001060.6 | ENSP00000364336 | P1 | ||
TBXA2R | ENST00000589966.1 | c.*578C>T | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000468145 | ||||
TBXA2R | ENST00000411851.3 | c.1087C>T | p.Arg363Ter | stop_gained | 4/4 | 2 | ENSP00000393333 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 151974Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000114 AC: 16AN: 140504Hom.: 0 AF XY: 0.000106 AC XY: 8AN XY: 75692
GnomAD3 exomes
AF:
AC:
16
AN:
140504
Hom.:
AF XY:
AC XY:
8
AN XY:
75692
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000194 AC: 267AN: 1379200Hom.: 0 Cov.: 29 AF XY: 0.000179 AC XY: 122AN XY: 680770
GnomAD4 exome
AF:
AC:
267
AN:
1379200
Hom.:
Cov.:
29
AF XY:
AC XY:
122
AN XY:
680770
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74370
GnomAD4 genome
AF:
AC:
17
AN:
152094
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TBXA2R-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 26, 2024 | The TBXA2R c.1087C>T variant is predicted to result in premature protein termination (p.Arg363*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.027% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Few loss-of-function variants have been reported in this gene to date in association with disease (Human Gene Mutation Database; https://www.hgmd.cf.ac.uk/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MutationTaster
Benign
D;N;N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at